Microglia P2Y6 receptors mediate nitric oxide release and astrocyte apoptosis

被引:47
|
作者
Quintas, Clara [1 ,2 ]
Pinho, Diana [1 ,2 ]
Pereira, Clara [2 ,3 ]
Saraiva, Lucilia [2 ,3 ]
Goncalves, Jorge [1 ,2 ]
Queiroz, Gloria [1 ,2 ]
机构
[1] Univ Porto, Fac Pharm, REQUIMTE, Dept Drug Sci,Lab Pharmacol, P-4050313 Oporto, Portugal
[2] Univ Porto, Fac Pharm, Ctr Drug Discovery & Innovat Med, P-4050313 Oporto, Portugal
[3] Univ Porto, Fac Pharm, REQUIMTE, Dept Biol Sci,Lab Microbiol, P-4050313 Oporto, Portugal
来源
JOURNAL OF NEUROINFLAMMATION | 2014年 / 11卷
关键词
lipopolysaccharide; astroglial proliferation; microglia; uracil nucleotides; P2Y(6) receptors; nitric oxide; apoptosis; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; NUCLEOTIDE RECEPTORS; ACTIVATED MICROGLIA; CELL ACTIVATION; INNATE IMMUNITY; RAT ASTROCYTES; BRAIN; PROLIFERATION; EXPRESSION;
D O I
10.1186/s12974-014-0141-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: During cerebral inflammation uracil nucleotides leak to the extracellular medium and activate glial pyrimidine receptors contributing to the development of a reactive phenotype. Chronically activated microglia acquire an anti-inflammatory phenotype that favors neuronal differentiation, but the impact of these microglia on astrogliosis is unknown. We investigated the contribution of pyrimidine receptors to microglia-astrocyte signaling in a chronic model of inflammation and its impact on astrogliosis. Methods: Co-cultures of astrocytes and microglia were chronically treated with lipopolysaccharide (LPS) and incubated with uracil nucleotides for 48 h. The effect of nucleotides was evaluated in methyl-[3H]-thymidine incorporation. Western blot and immunofluorescence was performed to detect the expression of P2Y(6) receptors and the inducible form of nitric oxide synthase (iNOS). Nitric oxide (NO) release was quantified through Griess reaction. Cell death was also investigated by the LDH assay and by the TUNEL assay or Hoechst 33258 staining. Results: UTP, UDP (0.001 to 1 mM) or PSB 0474 (0.01 to 10 mu M) inhibited cell proliferation up to 43 +/- 2% (n = 10, P < 0.05), an effect prevented by the selective P2Y(6) receptor antagonist MRS 2578 (1 mu M). UTP was rapidly metabolized into UDP, which had a longer half-life. The inhibitory effect of UDP (1 mM) was abolished by phospholipase C (PLC), protein kinase C (PKC) and nitric oxide synthase (NOS) inhibitors. Both UDP (1 mM) and PSB 0474 (10 mu M) increased NO release up to 199 +/- 20% (n = 4, P < 0.05), an effect dependent on P2Y(6) receptors-PLC-PKC pathway activation, indicating that this pathway mediates NO release. Western blot and immunocytochemistry analysis indicated that P2Y(6) receptors were expressed in the cultures being mainly localized in microglia. Moreover, the expression of iNOS was mainly observed in microglia and was upregulated by UDP (1 mM) or PSB 0474 (10 mu M). UDP-mediated NO release induced apoptosis in astrocytes, but not in microglia. Conclusions: In LPS treated co-cultures of astrocytes and microglia, UTP is rapidly converted into UDP, which activates P2Y6 receptors inducing the release of NO by microglia that causes astrocyte apoptosis, thus controlling their rate of proliferation and preventing an excessive astrogliosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
    Koizumi, Schuichi
    Shigemoto-Mogami, Yukari
    Nasu-Tada, Kaoru
    Shinozaki, Yoichi
    Ohsawa, Keiko
    Tsuda, Makoto
    Joshi, Bhalchandra V.
    Jacobson, Kenneth A.
    Kohsaka, Shinichi
    Inoue, Kazuhide
    NATURE, 2007, 446 (7139) : 1091 - 1095
  • [22] A role for P2Y6 receptor in regulation of islet hormone release
    Parandeh, Fariborz
    Amisten, Stefan
    Meidute, Sandra
    Erlinge, David
    Salehi, Albert
    PURINERGIC SIGNALLING, 2008, 4 : S50 - S50
  • [23] Different Roles for P2Y2 and P2Y6 Receptors in Large and Smaller Coronary Arteries
    Haanes, Kristian
    Larsen, Stine
    Syberg, Susanne
    Jorgensen, Niklas
    Robaye, Bernard
    Boeynaems, Jean-Marie
    Edvinsson, Lars
    FASEB JOURNAL, 2015, 29
  • [24] P2Y6 receptor and immunoinflammation
    Liu, Gui-Dong
    Ding, Jian-Qing
    Xiao, Qin
    Chen, Sheng-Di
    NEUROSCIENCE BULLETIN, 2009, 25 (03) : 161 - 164
  • [25] Different roles for P2Y2 and P2Y6 receptors in large and smaller coronary arteries
    Haanes, Kristian Agmund
    Spray, Stine
    Syberg, Susanne
    Jorgensen, Niklas Rye
    Robaye, Bernard
    Boeynaems, Jean-Marie
    Edvinsson, Lars
    ACTA PHYSIOLOGICA, 2015, 215 : 8 - 9
  • [26] P2Y6 and vascular inflammation
    Blackburn, Michael R.
    BLOOD, 2011, 117 (08) : 2304 - 2305
  • [27] Diisothiocyanate derivatives as potent, insurmountable antagonists of P2y6 nucleotide receptors
    Mamedova, LK
    Joshi, BV
    Gao, ZG
    von Kügelgen, I
    Jacobson, KA
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (09) : 1763 - 1770
  • [28] Machine learning-aided search for ligands of P2Y6 and other P2Y receptors
    Puhl, Ana C.
    Lewicki, Sarah A.
    Gao, Zhan-Guo
    Pramanik, Asmita
    Makarov, Vadim
    Ekins, Sean
    Jacobson, Kenneth A.
    PURINERGIC SIGNALLING, 2024, 20 (06) : 617 - 627
  • [29] Microglia P2Y6 receptor is related to Parkinson's disease through neuroinflammatory process
    Yang, Xiaodong
    Lou, Yue
    Liu, Guidong
    Wang, Xueping
    Qian, Yiwei
    Ding, Jianqing
    Chen, Shengdi
    Xiao, Qin
    JOURNAL OF NEUROINFLAMMATION, 2017, 14
  • [30] P2Y receptors on astrocytes and microglia mediate opposite effects in astroglial proliferation
    Clara Quintas
    Sónia Fraga
    Jorge Gonçalves
    Glória Queiroz
    Purinergic Signalling, 2011, 7 : 251 - 263